PRTA

9.13

1.78% 0.16

Handel nachbörslich: 9.13

Prothena Corporation Plc (PRTA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PRTA? Forum Prognose

Schlusskurs vom Vortag:

$8.97

Offen:

24-Stunden-Volumen:

466.10K

Relative Volume:

0.73

Marktkapitalisierung:

$491.47M

Einnahmen:

$217.25M

Nettoeinkommen (Verlust:

$-50.92M

KGV:

-9.13

EPS:

-1

Netto-Cashflow:

$-100.85M

1W Leistung:

-4.40%

1M Leistung:

-17.52%

6M Leistung:

+45.15%

1J Leistung:

-35.48%

1-Tages-Spanne:

$8.96

$9.465

1-Wochen-Bereich:

$8.885

$9.69

52-Wochen-Spanne:

$4.32

$16.66

Prothena Corporation Plc Stock (PRTA) Company Profile

Firmenname

Prothena Corporation Plc

Sektor

Healthcare (1120)

Branche

Biotechnology (625)

Telefon

011-353-1-236-2500

Adresse

77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2

Mitarbeiter

163

Twitter

@ProthenaCorp

Nächster Verdiensttermin

2025-02-18

Neueste SEC-Einreichungen

PRTA's Discussions on Twitter

Vergleichen Sie PRTA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PRTA Prothena Corporation Plc	9.13	482.85M	217.25M	-50.92M	-100.85M	-1.00
VRTX Vertex Pharmaceuticals Inc	484.15	118.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	812.27	81.61B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	422.50	53.69B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.94	49.49B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.00	37.34B	447.02M	-1.18B	-906.14M	-6.1812

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-28	Herabstufung	BofA Securities	Neutral → Underperform
2025-05-27	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2025-05-27	Herabstufung	Jefferies	Buy → Hold
2025-05-27	Herabstufung	Oppenheimer	Outperform → Perform
2024-12-20	Eingeleitet	Chardan Capital Markets	Buy
2024-01-30	Herabstufung	BofA Securities	Buy → Neutral
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-04-24	Eingeleitet	SVB Securities	Outperform
2023-01-27	Eingeleitet	Piper Sandler	Overweight
2022-11-04	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-09-28	Hochstufung	BofA Securities	Neutral → Buy
2021-11-19	Eingeleitet	JMP Securities	Mkt Outperform
2021-06-18	Hochstufung	BofA Securities	Underperform → Neutral
2021-06-08	Bestätigt	Oppenheimer	Outperform
2021-05-26	Eingeleitet	Citigroup	Buy
2021-02-26	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2021-02-12	Hochstufung	Jefferies	Hold → Buy
2021-02-02	Hochstufung	BTIG Research	Neutral → Buy
2020-12-07	Eingeleitet	H.C. Wainwright	Buy
2020-07-09	Hochstufung	Oppenheimer	Perform → Outperform
2019-11-19	Hochstufung	Evercore ISI	In-line → Outperform
2018-05-21	Herabstufung	Barclays	Equal Weight → Underweight
2018-04-23	Herabstufung	Jefferies	Buy → Hold
2018-04-05	Bestätigt	Barclays	Overweight
2017-11-20	Herabstufung	Wedbush	Outperform → Neutral
2017-09-29	Bestätigt	BTIG Research	Buy
2017-09-15	Eingeleitet	RBC Capital Mkts	Outperform
2017-08-17	Eingeleitet	Evercore ISI	Outperform
2017-07-11	Eingeleitet	Jefferies	Buy
2017-04-12	Eingeleitet	Cantor Fitzgerald	Overweight
2017-04-12	Eingeleitet	Piper Jaffray	Overweight
2017-03-02	Eingeleitet	Instinet	Buy
2016-12-21	Eingeleitet	SunTrust	Buy
2016-11-03	Eingeleitet	Deutsche Bank	Buy
2016-08-04	Bestätigt	Barclays	Overweight
2016-05-13	Eingeleitet	Barclays	Overweight
2016-02-19	Bestätigt	Wedbush	Outperform
2016-01-21	Eingeleitet	Credit Suisse	Outperform

Alle ansehen

Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten

Jan 05, 2026

How Are Partnered Pipelines Rewriting The Prothena (PRTA) Narrative And Price Target Outlook - Yahoo Finance UK

Jan 05, 2026

Macro Review: What valuation multiples suggest for Prothena Corporation plc stockWeekly Profit Summary & Long Hold Capital Preservation Plans - moha.gov.vn

Jan 05, 2026

Jan 02, 2026

We Think Prothena (NASDAQ:PRTA) Can Afford To Drive Business Growth - Yahoo Finance

Jan 02, 2026

(PRTA) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Jan 02, 2026

Dec 26, 2025

Prothena announces board of directors update - MSN

Dec 26, 2025

Dec 25, 2025

89,704 Shares in Prothena Corporation plc $PRTA Acquired by Assenagon Asset Management S.A. - Defense World

Dec 25, 2025

Dec 22, 2025

(PRTA) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Dec 22, 2025

Dec 21, 2025

Prothena Corporation plc(NasdaqGS:PRTA) added to S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025

Squarepoint Ops LLC Takes $1.27 Million Position in Prothena Corporation plc $PRTA - Defense World

Dec 21, 2025

Dec 20, 2025

Earnings Miss: Why Prothena Corporation plc stock remains undervaluedStock Surge & Fast Entry Momentum Trade Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Why Prothena Corporation plc stock remains undervaluedDip Buying & Free High Return Stock Watch Alerts - Улправда

Dec 19, 2025

What catalysts could drive Prothena Corporation plc stock higherDip Buying & AI Based Trade Execution Alerts - DonanımHaber

Dec 19, 2025

Dec 17, 2025

Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Dec 17, 2025

Dec 13, 2025

Birchview Capital LP Has $2.74 Million Stock Holdings in Prothena Corporation plc $PRTA - MarketBeat

Dec 13, 2025

Prothena Board Member Paula Cobb Resigns - The Globe and Mail

Dec 13, 2025

Dec 12, 2025

Paula Cobb steps down from Prothena’s board to join Manifold Bio - Investing.com Nigeria

Dec 12, 2025

Paula Cobb steps down from Prothena’s board to join Manifold Bio By Investing.com - Investing.com South Africa

Dec 12, 2025

[8-K] PROTHENA CORP PUBLIC LTD CO Reports Material Event | PRTA SEC FilingForm 8-K - Stock Titan

Dec 12, 2025

Prothena Announces Board of Directors Update - Yahoo Finance

Dec 12, 2025

What analysts say about Prothena Corporation plc stockMean Reversion Trades & Free Harness Proven Investment Plans - earlytimes.in

Dec 12, 2025